Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IBI310 |
Synonyms | |
Therapy Description |
IBI310 is an antibody targeting CTLA4 (CD152), which potentially decreases tumor growth (Ann Oncol (2023) 34 (suppl_2): S221). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IBI310 | IBI-310|IBI 310 | CTLA4 Antibody 29 | IBI310 is an antibody targeting CTLA4 (CD152), which potentially decreases tumor growth (Ann Oncol (2023) 34 (suppl_2): S221). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|